# ![@kakulukeka Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::1740403300539727872.png) @kakulukeka ss

ss posts on X about sanofi, caps, sentiment, acquisition the most. They currently have [--] followers and [--] posts still getting attention that total [--] engagements in the last [--] hours.

### Engagements: [--] [#](/creator/twitter::1740403300539727872/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1740403300539727872/c:line/m:interactions.svg)

- [--] Month [-----] +1,841%
- [--] Months [-----] +1,215%

### Mentions: [--] [#](/creator/twitter::1740403300539727872/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1740403300539727872/c:line/m:posts_active.svg)


### Followers: [--] [#](/creator/twitter::1740403300539727872/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1740403300539727872/c:line/m:followers.svg)

- [--] Month [--] +16%
- [--] Months [--] +267%

### CreatorRank: undefined [#](/creator/twitter::1740403300539727872/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::1740403300539727872/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[stocks](/list/stocks)  [finance](/list/finance)  [technology brands](/list/technology-brands)  [automotive brands](/list/automotive-brands) 

**Social topic influence**
[sanofi](/topic/sanofi), [caps](/topic/caps), [sentiment](/topic/sentiment), [acquisition](/topic/acquisition), [saving](/topic/saving), [rfk](/topic/rfk), [money](/topic/money), [bms](/topic/bms), [ss](/topic/ss), [federal reserve](/topic/federal-reserve)

**Top accounts mentioned or mentioned by**
[@matthewherper](/creator/undefined) [@bradloncar](/creator/undefined) [@adamfeuerstein](/creator/undefined) [@lifescivc](/creator/undefined) [@jacobplieth](/creator/undefined) [@grok](/creator/undefined) [@jmaraganore](/creator/undefined) [@robertfsiegmund](/creator/undefined) [@johnwmaki](/creator/undefined) [@visualcap](/creator/undefined) [@sciencescanner](/creator/undefined) [@cgarthwaite](/creator/undefined) [@bioclouseau](/creator/undefined) [@atrupar](/creator/undefined) [@stillgray](/creator/undefined) [@aggregategains](/creator/undefined) [@pemulisking](/creator/undefined) [@rnpsi](/creator/undefined) [@johncendpts](/creator/undefined) [@aamortazavi](/creator/undefined)

**Top assets mentioned**
[Sanofi (SNY)](/topic/sanofi) [Tesla, Inc. (TSLA)](/topic/tesla) [Alphabet Inc Class A (GOOGL)](/topic/$googl)
### Top Social Posts
Top posts by engagements in the last [--] hours

"@adamfeuerstein @JMaraganore National Priority Voucher program sounds like Trumps Gold Card - vague and nobody knows how to qualify"  
[X Link](https://x.com/kakulukeka/status/1935170182768632192)  2025-06-18T02:58Z [--] followers, [---] engagements


"@robertfsiegmund @John_W_Maki @VisualCap Vertex had [----] revenues of [----] billion vs Pfizer [---] billions their market caps are similar How does that make any sense"  
[X Link](https://x.com/kakulukeka/status/1952444155839328459)  2025-08-04T18:58Z [--] followers, [--] engagements


"@sciencescanner @matthewherper Speculative articles with agenda does not help sentiment either"  
[X Link](https://x.com/kakulukeka/status/1955262804270764460)  2025-08-12T13:39Z [--] followers, [--] engagements


"@matthewherper @C_Garthwaite @LifeSciVC I agree it is not a bad return. But what if that becomes a $10 B revenue per year asset Subsequent to Merck acquisition of Schering Pembro was put on out licensing assets. It was pulled out only after BMS presented hot data from Obdivo. The rest is history So you never know"  
[X Link](https://x.com/kakulukeka/status/1965525085382737974)  2025-09-09T21:17Z [--] followers, [--] engagements


"@bradloncar Not just KVUE/JNJ you can pretty much say that for every major company Pharma/biotech despite producing life saving drugs have ended up as a villains Hard to comprehend that The onslaught will continue under RFK Jr"  
[X Link](https://x.com/kakulukeka/status/1970586931357515975)  2025-09-23T20:31Z [--] followers, [---] engagements


"@JacobPlieth @bradloncar If you are a shareholder not much. In terms of revenue she did alright"  
[X Link](https://x.com/kakulukeka/status/1972614381197578501)  2025-09-29T10:48Z [--] followers, [--] engagements


"@LifeSciVC BMS BD is known for stupid deals It is unlikely that their cell therapies make any profit despite over billion dollar revenue Better off spinning off into a separate company than sinking more money into cell therapies"  
[X Link](https://x.com/kakulukeka/status/1976756419861881219)  2025-10-10T21:07Z [--] followers, [---] engagements


"@bio_clouseau Take a look at JNJ portfolio of products. Most blockbusters are from licensing and not from internal discovery. So he can STFU about how great their discovery chemistry is Needless comments about their partner"  
[X Link](https://x.com/kakulukeka/status/1978460973259219113)  2025-10-15T14:00Z [--] followers, [--] engagements


"@atrupar Brilliant He just figured out federal reserve ATM code 😂"  
[X Link](https://x.com/kakulukeka/status/1980879038894973318)  2025-10-22T06:09Z [--] followers, [--] engagements


"@stillgray Arrogant prick"  
[X Link](https://x.com/kakulukeka/status/1986846592750559239)  2025-11-07T17:21Z [--] followers, [--] engagements


"@aggregategains @adamfeuerstein @pemulisking I guess you want another serapta Ok"  
[X Link](https://x.com/kakulukeka/status/1988805619042906413)  2025-11-13T03:06Z [--] followers, [--] engagements


"@JacobPlieth Not a bad idea. Will be hard to find a meaningful TI"  
[X Link](https://x.com/kakulukeka/status/1990511292826996745)  2025-11-17T20:04Z [--] followers, [--] engagements


"@matthewherper Lot of misinfo- the decision to approve a drug is not in the hands of ind reviewers but collective assessment of benefit-risk profile and the unmet medical need. Commissionerss priority voucher is a new program therefore unprecedented by definition. Comm can do per his wish"  
[X Link](https://x.com/kakulukeka/status/1992003162103066741)  2025-11-21T22:52Z [--] followers, [---] engagements


"@Rn_Psi @JohnCendpts I suggest you to copy your reply and paste into ChatGPT and ask how accurate it is You will see nuances Vaccines help but the benefit-risk profile across all age groups not the same for mRNA covid vacc. You would not care for stats if it is one of your loved one affected"  
[X Link](https://x.com/kakulukeka/status/1996545535319408858)  2025-12-04T11:42Z [--] followers, [--] engagements


"@grok @AAMortazavi @Papa_Heme How the heck 95% CI is 0.75-0.76 for an HR of [----] Is this real"  
[X Link](https://x.com/kakulukeka/status/1998957125104709757)  2025-12-11T03:24Z [--] followers, [--] engagements


"@doepke_michel Unfortunately this will become norm for next [--] years - FDA will most likely miss review and approval dates - not because they cant review but to answer constant interference from top. The impact of changes last year will be felt this year just saying"  
[X Link](https://x.com/kakulukeka/status/2011841873032155161)  2026-01-15T16:44Z [--] followers, [--] engagements


"@Dogstoyesky @davidaxelrod Lets be honest and say neither deserves it. Dont pit one against the other and miss the main point"  
[X Link](https://x.com/kakulukeka/status/2012151431412015581)  2026-01-16T13:14Z [--] followers, [--] engagements


"@XFreeze @grok verify Elons statement that Tesla is far advanced than Google self- driving"  
[X Link](https://x.com/kakulukeka/status/2012313823588344160)  2026-01-16T23:59Z [--] followers, [--] engagements


"@chamath No; just like this comment which would not be predicted to come from a super successful person 😀. MD admissions are super competitive and MCAT score range is too narrow to develop meaningful correlations with a subjective measure"  
[X Link](https://x.com/kakulukeka/status/2017088387430097140)  2026-01-30T04:12Z [--] followers, [--] engagements


"@matthewherper @DrMakaryFDA Extremely troubling trend for biotechs for developing novel therapies cant move goal posts after filing. How can a company develop therapies if they are not sure despite following procedures whether their products are accepted for review FDA is not one man show"  
[X Link](https://x.com/kakulukeka/status/2021381713440670108)  2026-02-11T00:32Z [--] followers, [----] engagements


"@ByMadeleineA @bradloncar Now PFE follow Sanofi and do the same in the best interest of shareholders"  
[X Link](https://x.com/kakulukeka/status/2021906493281603739)  2026-02-12T11:17Z [--] followers, [--] engagements


"@yaireinhorn @sanofi @WSJ The Board should be commended for replacing one failure with another 😂"  
[X Link](https://x.com/kakulukeka/status/2022313735751143555)  2026-02-13T14:15Z [--] followers, [--] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing